IL17RB and ovarian cancer: Pan et al. found ovarian cancer cells with overexpression of CRL4 were more sensitive to MLN4924 treatment than normal cells, such as ovarian surface epithelial cells and knockdown of CRL4 components in ovarian cancer cells mimicked the growth inhibition effects of MLN4924 [121].